Science Business pdf epub mobi txt 電子書下載2025

☆☆☆☆☆

Gary Pisano is the Harry E. Figgie Professor of Business Administration at the Harvard Business School. He joined the Harvard faculty in 1988. Pisano’s research, teaching, and consulting have focused on technology strategy, the management of innovation and intellectual property, competitive strategy, and manufacturing and outsourcing strategy. His work on these issues spans a range of science and technology based industries including aerospace, biotechnology and pharmaceuticals, specialty chemicals, health care, nutrition, computers, software, telecommunications, and semiconductors.

出版者:Harvard Business Review Press

作者:Gary P. Pisano

出品人:

頁數:256

译者:

出版時間:2006-11-1

價格:GBP 25.00

裝幀:Hardcover

isbn號碼:9781591398400

叢書系列:

圖書標籤:

生物産業
business
科技
生物
innovation
蓋茨推薦
沒有資源
比爾蓋茨清單

下載連結在頁面底部

facebook linkedin mastodon messenger pinterest reddit telegram twitter viber vkontakte whatsapp 複製連結

想要找書就要到圖書目錄大全

book.wenda123.org

立刻按 ctrl+D收藏本頁

你會得到大驚喜!!

Why has the biotechnology industry failed to perform up to expectations - despite all its promise? In "Science Business", Gary P. Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals the underlying causes of biotech's problems; he offers the most sophisticated analysis yet on how the industry works. And he provides clear prescriptions for companies, investors, and policy makers seeking ways to improve the industry's performance. According to Pisano, the biotech industry's problems stem from its special character as a science-based business. This character poses three unique business challenges: how to finance highly risky investments under profound uncertainty and long time horizons for R&D, how to learn rapidly enough to keep pace with advances in drug science knowledge, and how to integrate capabilities across a broad spectrum of scientific and technological knowledge bases.The key to fixing the industry? Business models, organisational structures, and financing arrangements that place greater emphasis on integration and long-term learning over shorter - term 'monetisation' of intellectual property. Pisano maintains that all industry players - biotech firms, investors, universities, pharmaceutical companies, government regulators - can play a role in righting the industry. The payoff? Valuable improvements in health care, and a shinier future for human well-being.